Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Stepanishyna Y"'
Autor:
Stepanishyna Y; Hematology Department, Institute Jules Bordet., Meunier F; Founder of Ending discrimination against cancer survivors project, Brussels, Belgium., Bron D; Hematology Department, Institute Jules Bordet.
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2024 Sep 01; Vol. 36 (5), pp. 360-368. Date of Electronic Publication: 2024 Jun 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martelli M; Sapienza University, Division of Hematology, Department of Translational and Precision Medicine, Rome, Italy., Ceriani L; Institute of Oncology Research (IOR), Bellinzona, Switzerland.; Ente Ospedaliero Cantonale, Imaging Institute of Southern Switzerland, Lugano, Switzerland.; Università della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland., Ciccone G; AOU Città della Salute e della Scienza di Torino and CPO Piemonte, Clinical Epidemiology Unit, Turin, Italy., Ricardi U; University of Turin, Department of Oncology, Turin, Italy., Kriachok I; National Cancer Institute, Onco-Hematology Department, Kyiv, Ukraine., Botto B; AOU Città della Salute e della Scienza, Department of Hematology, Turin, Italy., Balzarotti M; IRCCS Humanitas Research Hospital, Department of Medical Oncology and Hematology, Rozzano Milan, Italy., Tucci A; ASST Spedali Civili, Department of Haematology, Brescia, Italy., Usai SV; AO Brotzu - Ospedale Oncologico Businco, Unit of Hematology and Bone Marrow Transplant, Cagliari, Italy., Zilioli VR; ASST Grande Ospedale Metropolitano Niguarda, Division of Hematology, Milan, Italy., Pennese E; Presidio Ospedaliero Pescara, Unità Operativa Semplice Dipartimentale Centro Diagnosi e Terapia Linfomi, Pescara, Italy., Arcaini L; University of Pavia, Department of Molecular Medicine, Pavia, Italy.; Fondazione IRCCS Policlinico San Matteo, Division of Hematology, Pavia, Italy., Dabrowska-Iwanicka A; Maria Sklodowska-Curie National Research Institute of Oncology, Department of Lymphoid Malignancies, Warsaw, Poland., Ferreri AJM; IRCCS San Raffaele Scientific Institute, Lymphoma Unit, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy., Merli F; Azienda USL-IRCCS of Reggio Emilia, Department of Hematology, Reggio Emilia, Italy., Zhao W; Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China., Rigacci L; AOU Careggi, Department of Hematology, Florence, Italy., Cellini C; Ospedale Santa Maria delle Croci, Department of Hematology, Ravenna, Italy., Hodgson D; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, Canada., Ionescu C; Inselspital, Bern University Hospital, University of Bern, Department of Radiation Oncology, Bern, Switzerland., Minoia C; IRCCS Istituto Tumori Giovanni Paolo II, Hematology Unit, Bari, Italy., Lucchini E; ASU Friuli Centrale, Unit of Hematology, Udine, Italy.; ASU Giuliano Isontina, Ospedale Maggiore, Trieste, Italy., Spina M; Centro di Riferimento Oncologico IRCCS, Division of Medical Oncology and Immunerelated Tumors, Aviano, Italy., Fosså A; Oslo University Hospital, Department of Oncology, Oslo, Norway.; University of Oslo, KG Jebsen Center for B-cell malignancies, Oslo, Norway., Janikova A; University Hospital Brno, Brno, Czech Republic., Cwynarski K; University College London Hospitals NHS Trust, Department of Hematology, London, United Kingdom., Mikhaeel G; Guy's and St Thomas' NHS Foundation Trust, Guy's Cancer Center, London, United Kingdom., Jerkeman M; Skane University Hospital, Department of Oncology, Lund University, Lund, Sweden., Di Rocco A; Sapienza University, Division of Hematology, Department of Translational and Precision Medicine, Rome, Italy., Stepanishyna Y; National Cancer Institute, Onco-Hematology Department, Kyiv, Ukraine., Vitolo U; AOU Città della Salute e della Scienza, Department of Hematology, Turin, Italy.; Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo Cancer Institute, Candiolo, Italy., Santoro A; IRCCS Humanitas Research Hospital, Department of Medical Oncology and Hematology, Rozzano Milan, Italy.; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy., Re A; ASST Spedali Civili, Department of Haematology, Brescia, Italy., Puccini B; AOU Careggi, Department of Hematology, Florence, Italy., Olivieri J; ASU Friuli Centrale, Unit of Hematology, Udine, Italy., Petrucci L; Sapienza University, Division of Hematology, Department of Translational and Precision Medicine, Rome, Italy., Barrington SF; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, United Kingdom., Malkowski B; Nicolaus Copernicus University, Department of Diagnostics Imagining, Torun, Poland., Metser U; University Health Network, Princess Margaret Hospital, University Medical Imaging Toronto, University of Toronto, Toronto, Canada., Versari A; Azienda USL-IRCCS of Reggio Emilia, Department of Nuclear Medicine, Oncology and High Technology, Reggio Emilia, Italy., Chauvie S; AO Santa Croce e Carle, Department of Medical Physics, Cuneo, Italy., Walewski J; Maria Sklodowska-Curie National Research Institute of Oncology, Department of Lymphoid Malignancies, Warsaw, Poland., Trneny M; Charles University, General Hospital, Department of Medical Oncology, Prague, Czech Republic., Cavalli F; Institute of Oncology Research (IOR), Bellinzona, Switzerland., Gospodarowicz M; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, Canada., Johnson PWM; University of Southampton, Clinical Trials Unit, School of Cancer Sciences, Southampton, United Kingdom., Davies A; University of Southampton, Clinical Trials Unit, School of Cancer Sciences, Southampton, United Kingdom., Zucca E; Institute of Oncology Research (IOR), Bellinzona, Switzerland.; Università della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.; Ente Ospedaliero Cantonale, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 19, pp. JCO2401373. Date of Electronic Publication: 2024 Aug 19.
Autor:
Federico M; Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy; Wouter Plattel, MD, University Medical Center Groningen, Groningen, the Netherlands; Martin Hutchings, MD, Rigshospitalet, Copenhagen, Denmark; Yana Stepanishyna, MD, Haematology Department, Jules Bordet Institute, Brussels, Belgium, National Cancer Institute, Kyiv, Ukraine; Catherine Fortpied, MSc, EORTC Headquarters, Brussels, Belgium; and Marc André, MD, CHU UCL Namur, Yvoir, Belgium., Plattel W; Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy; Wouter Plattel, MD, University Medical Center Groningen, Groningen, the Netherlands; Martin Hutchings, MD, Rigshospitalet, Copenhagen, Denmark; Yana Stepanishyna, MD, Haematology Department, Jules Bordet Institute, Brussels, Belgium, National Cancer Institute, Kyiv, Ukraine; Catherine Fortpied, MSc, EORTC Headquarters, Brussels, Belgium; and Marc André, MD, CHU UCL Namur, Yvoir, Belgium., Hutchings M; Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy; Wouter Plattel, MD, University Medical Center Groningen, Groningen, the Netherlands; Martin Hutchings, MD, Rigshospitalet, Copenhagen, Denmark; Yana Stepanishyna, MD, Haematology Department, Jules Bordet Institute, Brussels, Belgium, National Cancer Institute, Kyiv, Ukraine; Catherine Fortpied, MSc, EORTC Headquarters, Brussels, Belgium; and Marc André, MD, CHU UCL Namur, Yvoir, Belgium., Stepanishyna Y; Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy; Wouter Plattel, MD, University Medical Center Groningen, Groningen, the Netherlands; Martin Hutchings, MD, Rigshospitalet, Copenhagen, Denmark; Yana Stepanishyna, MD, Haematology Department, Jules Bordet Institute, Brussels, Belgium, National Cancer Institute, Kyiv, Ukraine; Catherine Fortpied, MSc, EORTC Headquarters, Brussels, Belgium; and Marc André, MD, CHU UCL Namur, Yvoir, Belgium., Fortpied C; Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy; Wouter Plattel, MD, University Medical Center Groningen, Groningen, the Netherlands; Martin Hutchings, MD, Rigshospitalet, Copenhagen, Denmark; Yana Stepanishyna, MD, Haematology Department, Jules Bordet Institute, Brussels, Belgium, National Cancer Institute, Kyiv, Ukraine; Catherine Fortpied, MSc, EORTC Headquarters, Brussels, Belgium; and Marc André, MD, CHU UCL Namur, Yvoir, Belgium., André M; Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy; Wouter Plattel, MD, University Medical Center Groningen, Groningen, the Netherlands; Martin Hutchings, MD, Rigshospitalet, Copenhagen, Denmark; Yana Stepanishyna, MD, Haematology Department, Jules Bordet Institute, Brussels, Belgium, National Cancer Institute, Kyiv, Ukraine; Catherine Fortpied, MSc, EORTC Headquarters, Brussels, Belgium; and Marc André, MD, CHU UCL Namur, Yvoir, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 20; Vol. 42 (18), pp. 2237-2238. Date of Electronic Publication: 2024 Apr 09.
Autor:
Stepanishyna Y; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.; Department of Hematology, Jules Bordet Institute, Brussels, Belgium., Manni M; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy., Civallero M; Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy., Shokun N; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine., Skrypets T; Hematology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Burtna A; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine., Shapovalenko N; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Tytorenko I; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Aleksyk O; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Pastushenko Y; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Gubareva H; Department of medical statistics and national cancer register, National Cancer Institute, Kyiv, Ukraine., Moiseienko K; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine., Kadnikova T; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Rudyuk T; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Filonenko K; Department of Hematology and Transplantology, University Clinical Center, Gdansk, Poland., Martynchyk A; Department of Hematology, Austin Health, Melbourne, Australia., Novosad O; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Galli GR; Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy., Kryachok I; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Federico M; Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1757-1761. Date of Electronic Publication: 2024 Feb 23.
Autor:
Kriachok I; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Tytorenko I; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Shudrak N; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Aleksik O; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Stepanishyna Y; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Kadnikova T; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Pastushenko Y; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Shokun N; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Rudiyk T; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Bushuieva M; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine.
Publikováno v:
Experimental oncology [Exp Oncol] 2024 Feb 03; Vol. 45 (4), pp. 474-482. Date of Electronic Publication: 2024 Feb 03.
Autor:
Federico M; University of Modena and Reggio Emilia, Modena, Italy., Fortpied C; EORTC Headquarters, Brussels, Belgium., Stepanishyna Y; National Cancer Institute, Kyiv, Ukraine., Gotti M; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., van der Maazen R; Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Cristinelli C; Hôpital Saint-Louis, Paris, France., Re A; Spedali Civili Hospital, Brescia, Italy., Plattel W; University Medical Center Groningen, Groningen, the Netherlands., Lazarovici J; Institut Goustave-Roussy, Paris, France., Merli F; Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, Italy., Specht L; Rigshospitalet, Copenhagen, Denmark., Schiano de Colella JM; Institut Paoli-Calmette, Marseille, France., Hutchings M; Rigshospitalet, Copenhagen, Denmark., Versari A; Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, Italy., Edeline V; Institut Curie, Paris, France., Stamatoulas A; Centre Henri Becquerel, Rouen, France., Girinsky T; Institut Gustave Roussy, Villejuif, France., Ricardi U; University of Turin, Turin, Italy., Aleman B; The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, the Netherlands., Meulemans B; EORTC Headquarters, Brussels, Belgium., Tonino S; Amsterdam University Medical Center, Amsterdam, the Netherlands., Raemaekers J; Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., André M; CHU UCL Namur, Yvoir, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 01; Vol. 42 (1), pp. 19-25. Date of Electronic Publication: 2023 Nov 15.
Autor:
Hapgood G; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Civallero M; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy., Stepanishyna Y; Kiev National Cancer Institute, Kiev, Ukraine., Vose J; University of Nebraska Medical Center, Omaha, NE., Cabrera ME; Hematology Section, Hospital del Salvador, University of Chile, Santiago de Chile, Chile., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Pileri SA; Division of Diagnostic Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Manni M; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy., Horwitz SM; Department Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Foss FM; Yale University School of Medicine, New Haven, CT., Hitz F; The Swiss Group for Clinical Cancer Research, Department of Oncology/Haematology, Cantonal Hospital, St. Gallen, Switzerland., Radford J; Medical Oncology, University of Manchester, Manchester, England., Dlouhy I; Clinic Barcelona, Hospital Universitari, Barcelona, Spain., Chiattone C; Santa Casa Medical School of Sao Paulo and Samaritan Hospital, Sao Paulo, Brazil., Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea., Skrypets T; Hematology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy., Nagler A; Hematology Division BMT and Cord Blood Bank Chaim Sheba Medical Center Tel-Hashomer, Ramat-Gan, Israel., Trotman J; Department of Haematology, Concord Hospital, University of Sydney, Sydney, Australia., Luminari S; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.; Hematology, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Federico M; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.
Publikováno v:
Blood advances [Blood Adv] 2023 Sep 12; Vol. 7 (17), pp. 5047-5054.
Publikováno v:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2022, Vol. 35 Issue 6, p448-453, 6p
Autor:
Kriachok I; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Stepanishyna Y; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine., Skrypets T; Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.; PhD School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy., Shokun N; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine., Martynchyk A; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine., Tytorenko I; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Aleksik O; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine., Krotevych M; Pathology Department, National Cancer Institute, Kyiv, Ukraine., Manni M; Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy., Federico M; Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Publikováno v:
Hematological oncology [Hematol Oncol] 2023 Feb; Vol. 41 (1), pp. 196-200. Date of Electronic Publication: 2022 Aug 19.